Ilex Capital Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Ilex Capital Partners's CL Position: Q3 2026 in Review
Ilex Capital Partners increased its Colgate-Palmolive (CL) stake by 59% in Q3 2026, buying an estimated $31.7M and bringing the position to 941,604 shares worth $80.3M. The position accounts for 1.56% of the portfolio, ranked #23.
Ilex Capital Partners first reported a position in CL in Q4 2023 and has held it in 7 quarters since. The position peaked at $165M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q3 2026.
- Ilex Capital Partners held 941,604 shares of Colgate-Palmolive worth $80.3M as of Q3 2026.
- Ilex Capital Partners bought 350,041 Colgate-Palmolive shares in Q3 2026, an estimated $31.7M.
- Colgate-Palmolive made up 1.56% of Ilex Capital Partners's portfolio in Q3 2026, its #23 holding.
- Ilex Capital Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 7 quarters since.
- Ilex Capital Partners's Colgate-Palmolive position peaked at $165M in Q4 2025.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.
Based on Ilex Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.